[Class II cytokine receptors and their ligands].
Takaoka
Akinori
A
Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo.
Yanai
Hideyuki
H
D000818:Animals; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D017209:Apoptosis / Q000235:genetics; D016207:Cytokines / Q000145:classification* / Q000502:physiology*; D004268:DNA-Binding Proteins / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents; D050832:Interferon-Stimulated Gene Factor 3; D050834:Interferon-Stimulated Gene Factor 3, gamma Subunit; D007372:Interferons / Q000502:physiology / Q000627:therapeutic use; D016753:Interleukin-10 / Q000502:physiology / Q000627:therapeutic use; D018121:Receptors, Cytokine / Q000145:classification* / Q000502:physiology*; D015398:Signal Transduction / Q000235:genetics* / Q000502:physiology; D014157:Transcription Factors / Q000502:physiology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D014777:Virus Diseases / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D016207:Cytokines; D004268:DNA-Binding Proteins; C494227:IRF9 protein, human; D007166:Immunosuppressive Agents; D050832:Interferon-Stimulated Gene Factor 3; D050834:Interferon-Stimulated Gene Factor 3, gamma Subunit; D018121:Receptors, Cytokine; D014157:Transcription Factors; D016159:Tumor Suppressor Protein p53; D016753:Interleukin-10; D007372:Interferons